Compare LAKE & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAKE | SRTS |
|---|---|---|
| Founded | 1982 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.2M | 79.3M |
| IPO Year | 2013 | 2016 |
| Metric | LAKE | SRTS |
|---|---|---|
| Price | $9.16 | $4.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $17.33 | $6.67 |
| AVG Volume (30 Days) | 84.3K | ★ 90.6K |
| Earning Date | 03-18-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.27% | N/A |
| EPS Growth | N/A | ★ 1266.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $167,211,000.00 | $41,807,000.00 |
| Revenue This Year | $19.87 | $31.80 |
| Revenue Next Year | $8.32 | $32.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2554.14 | 71.31 |
| 52 Week Low | $7.77 | $3.03 |
| 52 Week High | $23.87 | $5.92 |
| Indicator | LAKE | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 42.22 |
| Support Level | $8.70 | $3.63 |
| Resistance Level | $9.67 | $4.83 |
| Average True Range (ATR) | 0.38 | 0.23 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 10.82 | 36.91 |
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.